South Africa suspends use of AstraZeneca’s COVID-19 vaccine after it fails to clearly stop virus variant

by

“The South African trial of the vaccine, conducted in about 2000 people, found such a low efficacy against mild and moderate disease, under 25%, that it would not meet minimal international standards for emergency use.”

via Science
You might also like
Is the Worst of Africa’s COVID-19 Outbreak Over?
South Sudan Returning 72,000 COVID Vaccine Doses
It’s Been One Year Since the First COVID-19 Case in Africa: China’s Contribution & COVID-19 Year in Review
As officials argue over vaccine funding, the African country worst hit by the pandemic is fumbling its chance to limit the damage
COVID-19 sets HIV treatment and testing back (South Africa)
Why India is banking on health diplomacy to grow African footprint
More analysis from COVID-19 Africa Watch: